82 related articles for article (PubMed ID: 9852207)
21. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy.
Ohashi Y; Nakai Y; Sakamoto H; Ohno Y; Sugiura Y; Okamoto H; Tanaka A; Kakinoki Y; Kishimoto K; Hayashi M
Ann Allergy Asthma Immunol; 1996 Sep; 77(3):203-8. PubMed ID: 8814045
[TBL] [Abstract][Full Text] [Related]
22. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.
Naumnik W; Chyczewska E
Folia Histochem Cytobiol; 2001; 39 Suppl 2():185-6. PubMed ID: 11820599
[TBL] [Abstract][Full Text] [Related]
23. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
Orditura M; De Vita F; Roscigno A; Auriemma A; Infusino S; Catalano G
Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
[TBL] [Abstract][Full Text] [Related]
24. Effect of antitumor surgery on soluble interleukin-2 receptor serum levels.
Brivio F; Lissoni P; Mancini D; Tisi E; Tancini G; Barni S; Nociti V
Am J Surg; 1991 Apr; 161(4):466-9. PubMed ID: 1827961
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of increased serum soluble interleukin-2 receptor levels in patients on continuous ambulatory peritoneal dialysis.
Takemasa A; Yorioka N; Oda H; Amimoto D; Ito T; Yamakido M
Scand J Urol Nephrol; 2001 Apr; 35(2):141-6. PubMed ID: 11411658
[TBL] [Abstract][Full Text] [Related]
26. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
[TBL] [Abstract][Full Text] [Related]
27. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
[TBL] [Abstract][Full Text] [Related]
28. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
[TBL] [Abstract][Full Text] [Related]
29. Serum soluble interleukin-2 receptor and immunohistochemical staining of IL-2R/Tac antigen in gastric cancer.
Murakami S; Satomi A; Ishida K; Sakata H; Tsuji Y; Hibino S
Oncol Rep; 1996 Jan; 3(1):69-73. PubMed ID: 21594317
[TBL] [Abstract][Full Text] [Related]
30. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
[TBL] [Abstract][Full Text] [Related]
31. Soluble interleukin-2 receptors in pulmonary tuberculosis.
Ito M; Kojiro N; Shirasaka T; Ikeda T; Tachibana I; Mima T; Kokubu T
Jpn J Med; 1990; 29(6):583-6. PubMed ID: 2101408
[TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
[TBL] [Abstract][Full Text] [Related]
33. Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma.
Yamaguchi K; Nishimura Y; Kiyokawa T; Matsuzaki H; Ishii T; Kubota K; Kawahara M; Furuse K; Yoshinaga T; Kinuwaki E
J Lab Clin Med; 1990 Oct; 116(4):457-61. PubMed ID: 2170552
[TBL] [Abstract][Full Text] [Related]
34. Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis.
Pforte A; Brunner A; Gais P; Burger G; Breyer G; Ströbel M; Häussinger K; Ziegler-Heitbrock HW
Am Rev Respir Dis; 1993 Mar; 147(3):717-22. PubMed ID: 7680189
[TBL] [Abstract][Full Text] [Related]
35. Clinical value of soluble interleukin-2 receptor in infectious complications.
Iwagaki H; Hizuta A; Iwadou H; Perdomo JA; Tanaka N; Orita K
Acta Med Okayama; 1994 Aug; 48(4):225-6. PubMed ID: 7817778
[TBL] [Abstract][Full Text] [Related]
36. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
37. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
[TBL] [Abstract][Full Text] [Related]
38. The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels.
Volk HD; Josimovic-Alasevic O; Gross M; Diamantstein T
Clin Exp Immunol; 1989 Apr; 76(1):121-5. PubMed ID: 2786777
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.
Gebauer G; Rieger M; Jäger W; Lang N
Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184
[TBL] [Abstract][Full Text] [Related]
40. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
